Es gab 50 kürzliche Insider-Transaktionen für Incyte Corporation (INCY), darunter 16 Käufe und 33 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $8.39M und die gesamten Insider-Verkäufe auf $37.61M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Harrigan Edmund, Baker Bros. Advisors Lp, Clancy Paul J. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — INCY
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-31 |
Harrigan Edmund |
Director |
RSU-Zuteilung |
269 |
$94.12 |
$25.32K |
21,122 |
| 2026-03-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU-Zuteilung |
421 |
- |
- |
2,818,039 |
| 2026-03-31 |
Clancy Paul J |
Director |
RSU-Zuteilung |
265 |
$94.12 |
$24.94K |
23,741 |
| 2026-03-25 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU-Steuereinbehalt |
537 |
$92.23 |
$49.53K |
14,882 |
| 2026-03-17 |
Cagnoni Pablo J |
President, R&d |
Optionsausübung (Verkauf) |
7,166 |
$61.18 |
$438.42K |
9,102 |
| 2026-02-19 |
Cagnoni Pablo J |
President, R&d |
Optionsausübung (Verkauf) |
13,093 |
$61.76 |
$808.62K |
7,182 |
| 2026-02-02 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU-Steuereinbehalt |
185 |
$102.67 |
$18.99K |
34,065 |
| 2026-02-02 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU-Steuereinbehalt |
111 |
$102.67 |
$11.4K |
38,041 |
| 2026-01-20 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU-Steuereinbehalt |
429 |
$102.62 |
$44.02K |
34,250 |
| 2026-01-16 |
Cagnoni Pablo J |
President, R&d |
RSU-Zuteilung |
28,475 |
$106.21 |
$3.02M |
28,475 |
| 2026-01-16 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU-Zuteilung |
19,932 |
$106.21 |
$2.12M |
19,932 |
| 2026-01-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU-Zuteilung |
7,426 |
- |
- |
34,679 |
| 2026-01-16 |
Tray Thomas |
Principal Accounting Officer |
RSU-Zuteilung |
2,425 |
$106.21 |
$257.56K |
2,425 |
| 2026-01-16 |
Trotta Matteo |
EVP, GM, Dermatology Us |
RSU-Zuteilung |
8,542 |
$106.21 |
$907.25K |
8,542 |
| 2026-01-16 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU-Zuteilung |
8,911 |
- |
- |
38,152 |
| 2026-01-16 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU-Zuteilung |
14,237 |
$106.21 |
$1.51M |
14,237 |
| 2026-01-16 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU-Zuteilung |
4,218 |
$106.21 |
$447.99K |
4,218 |
| 2026-01-07 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
Informierter Verkauf |
10,856 |
$109.07 |
$1.18M |
66,132 |
| 2026-01-06 |
Issa Mohamed Khairie |
EVP, Head of Us Oncology |
RSU-Steuereinbehalt |
8,264 |
$106.66 |
$881.44K |
76,988 |
| 2026-01-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Informierter Verkauf |
15,634 |
$101.70 |
$1.59M |
34,203 |
| 2025-12-31 |
Harrigan Edmund |
Director |
RSU-Zuteilung |
245 |
$98.77 |
$24.2K |
20,853 |
| 2025-12-31 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU-Zuteilung |
328 |
- |
- |
2,817,618 |
| 2025-12-31 |
Clancy Paul J |
Director |
RSU-Zuteilung |
241 |
$98.77 |
$23.8K |
23,476 |
| 2025-12-31 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU-Steuereinbehalt |
13,292 |
$98.77 |
$1.31M |
49,837 |
| 2025-12-31 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU-Steuereinbehalt |
254 |
$98.77 |
$25.09K |
27,253 |
| 2025-12-19 |
Tray Thomas |
Principal Accounting Officer |
Optionsausübung (Verkauf) |
1,044 |
$95.76 |
$99.97K |
- |
| 2025-12-18 |
Tray Thomas |
Principal Accounting Officer |
Informierter Verkauf |
600 |
$98.25 |
$58.95K |
22,973 |
| 2025-12-17 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Informierter Verkauf |
4,323 |
$97.26 |
$420.45K |
27,507 |
| 2025-12-16 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
Informierter Verkauf |
53,175 |
$97.29 |
$5.17M |
31,830 |
| 2025-12-11 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Informierter Verkauf |
255 |
$94.94 |
$24.21K |
60,011 |
| 2025-12-10 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
Informierter Verkauf |
5,553 |
$95.58 |
$530.76K |
60,266 |
| 2025-12-08 |
Hoppenot Herve |
Director |
RSU-Steuereinbehalt |
2,843 |
$96.70 |
$274.92K |
326,803 |
| 2025-12-02 |
Stein Steven H |
EVP & Chief Medical Officer |
Informierter Verkauf |
20,105 |
$102.51 |
$2.06M |
63,129 |
| 2025-12-01 |
Stein Steven H |
EVP & Chief Medical Officer |
RSU-Steuereinbehalt |
17,093 |
$102.04 |
$1.74M |
83,234 |
| 2025-12-01 |
Morrissey Michael James |
EVP, Head of Tech. Operations |
RSU-Steuereinbehalt |
326 |
$102.04 |
$33.27K |
85,838 |
| 2025-12-01 |
Hoffman Richard A. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-12-01 |
Hoffman Richard A. |
EVP & General Counsel |
RSU-Zuteilung |
9,466 |
- |
- |
9,466 |
| 2025-11-24 |
Tray Thomas |
Principal Accounting Officer |
Informierter Verkauf |
600 |
$103.00 |
$61.8K |
23,573 |
| 2025-11-21 |
Tray Thomas |
Principal Accounting Officer |
Informierter Verkauf |
169 |
$102.00 |
$17.24K |
24,173 |
| 2025-11-17 |
Denton Sheila A. |
EVP & General Counsel |
Optionsausübung (Verkauf) |
278 |
$64.25 |
$17.86K |
8,883 |
| 2025-11-10 |
Hoppenot Herve |
Director |
Informierter Verkauf |
187,500 |
$105.46 |
$19.77M |
329,646 |
| 2025-11-05 |
Stein Steven H |
EVP & Chief Medical Officer |
Optionsausübung (Verkauf) |
1,194 |
$83.83 |
$100.09K |
- |
| 2025-11-04 |
Denton Sheila A. |
EVP & General Counsel |
Optionsausübung (Verkauf) |
598 |
$58.06 |
$34.72K |
13,765 |
| 2025-11-03 |
Heeson Lee |
EVP, Head of Incyte Intl |
Informierter Verkauf |
3,074 |
$94.02 |
$289.02K |
29,241 |
| 2025-10-15 |
Denton Sheila A. |
EVP & General Counsel |
Optionsausübung (Verkauf) |
277 |
$64.25 |
$17.8K |
9,161 |
| 2025-10-03 |
Denton Sheila A. |
EVP & General Counsel |
Informierter Verkauf |
3,501 |
$85.54 |
$299.48K |
26,569 |
| 2025-10-02 |
Denton Sheila A. |
EVP & General Counsel |
Optionsausübung (Verkauf) |
599 |
$58.06 |
$34.78K |
14,363 |
| 2025-10-01 |
Heeson Lee |
EVP, Head of Incyte Intl |
RSU-Steuereinbehalt |
463 |
$86.70 |
$40.14K |
32,315 |
| 2025-10-01 |
Mayes Patrick A |
EVP & Chief Scientific Officer |
RSU-Steuereinbehalt |
1,569 |
$86.70 |
$136.03K |
65,819 |
| 2025-09-30 |
Harrigan Edmund |
Director |
RSU-Zuteilung |
289 |
$84.81 |
$24.51K |
20,608 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
